Diabetes Clinical Trials in Sacramento, CA

20 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Metabolic Responses to Bariatric Surgery	—	University of California, Davis	<1 mi
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD	Phase 2	University of California, Davis	<1 mi
Use of CGM in Kidney Transplant Recipients	N/A	University of California, Davis	<1 mi
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes	N/A	University of California, Davis	<1 mi
Safer Aging With Diabetes Monitoring	N/A	Kaiser Permanente	<1 mi
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin	Phase 3	Eli Lilly and Company	<1 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes	Phase 3	Eli Lilly and Company	<1 mi
Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes	—	University of California, Davis	<1 mi
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM	Phase 3	AstraZeneca	<1 mi
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity	Phase 3	Pfizer	<1 mi
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus	Phase 3	AstraZeneca	<1 mi
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin	Phase 3	AstraZeneca	<1 mi
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes	Phase 3	Ascletis Pharma (China) Co., Limited	<1 mi
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin	Phase 3	AstraZeneca	<1 mi
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight	Phase 3	Novo Nordisk A/S	24 mi
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies	—	AstraZeneca	24 mi
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar	Phase 3	Boehringer Ingelheim	24 mi
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus	Phase 3	AstraZeneca	24 mi
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications	Phase 3	Novo Nordisk A/S	24 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)	Phase 2/3	CSL Behring	31 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.